INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

16.89 +0.24% (+0.04)

Over 5Y: -77.0%

2026-08-28
20 40 60 80
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q3 '21 — Revenue: 386.9M Q3 '21 — Operating Cash Flow: 82.8M Q3 '21 — Free Cash Flow: 75.5M Q3 '21 — Net Income: 43.2M Q4 '21 — Revenue: 405.5M Q4 '21 — Operating Cash Flow: 69.3M Q4 '21 — Free Cash Flow: 41.9M Q4 '21 — Net Income: 45.4M Q1 '22 — Revenue: 376.6M Q1 '22 — Operating Cash Flow: 44.3M Q1 '22 — Free Cash Flow: 35M Q1 '22 — Net Income: 32.9M Q2 '22 — Revenue: 397.8M Q2 '22 — Operating Cash Flow: 66.5M Q2 '22 — Free Cash Flow: 57.1M Q2 '22 — Net Income: 44.8M Q3 '22 — Revenue: 385.2M Q3 '22 — Operating Cash Flow: 68.3M Q3 '22 — Free Cash Flow: 59.2M Q3 '22 — Net Income: 49.9M Q4 '22 — Revenue: 398M Q4 '22 — Operating Cash Flow: 85.3M Q4 '22 — Free Cash Flow: 70.9M Q4 '22 — Net Income: 52.9M Q1 '23 — Revenue: 380.8M Q1 '23 — Operating Cash Flow: 26.2M Q1 '23 — Free Cash Flow: 12.5M Q1 '23 — Net Income: 24.2M Q2 '23 — Revenue: 381.3M Q2 '23 — Operating Cash Flow: 28.3M Q2 '23 — Free Cash Flow: 12.7M Q2 '23 — Net Income: 4.2M Q3 '23 — Revenue: 382.4M Q3 '23 — Operating Cash Flow: 26.8M Q3 '23 — Free Cash Flow: 13.7M Q3 '23 — Net Income: 19.5M Q4 '23 — Revenue: 397M Q4 '23 — Operating Cash Flow: 58.8M Q4 '23 — Free Cash Flow: 34.2M Q4 '23 — Net Income: 19.8M Q1 '24 — Revenue: 368.9M Q1 '24 — Operating Cash Flow: 15.8M Q1 '24 — Free Cash Flow: 291K Q1 '24 — Net Income: -3.3M Q2 '24 — Revenue: 418.2M Q2 '24 — Operating Cash Flow: 40.4M Q2 '24 — Free Cash Flow: 10.7M Q2 '24 — Net Income: -12.4M Q3 '24 — Revenue: 380.8M Q3 '24 — Operating Cash Flow: 22.5M Q3 '24 — Free Cash Flow: -7.2M Q3 '24 — Net Income: -10.7M Q4 '24 — Revenue: 442.6M Q4 '24 — Operating Cash Flow: 50.7M Q4 '24 — Free Cash Flow: 21.1M Q4 '24 — Net Income: 19.4M Q1 '25 — Revenue: 382.7M Q1 '25 — Operating Cash Flow: -11.3M Q1 '25 — Free Cash Flow: -40.2M Q1 '25 — Net Income: -25.3M Q2 '25 — Revenue: 415.6M Q2 '25 — Operating Cash Flow: 8.9M Q2 '25 — Free Cash Flow: -11.2M Q2 '25 — Net Income: -484.1M Q3 '25 — Revenue: 402.1M Q3 '25 — Operating Cash Flow: 40.9M Q3 '25 — Free Cash Flow: 25.8M Q3 '25 — Net Income: -5.4M Q4 '25 — Revenue: 434.9M Q4 '25 — Operating Cash Flow: 11.8M Q4 '25 — Free Cash Flow: -5.4M Q4 '25 — Net Income: -1.7M Q1 '26 — Revenue: 391.9M Q1 '26 — Operating Cash Flow: 9.8M Q1 '26 — Free Cash Flow: -5M Q1 '26 — Net Income: -4.6M Q2 '26 — Revenue: 418.8M Q2 '26 — Operating Cash Flow: 22.8M Q2 '26 — Free Cash Flow: 10.5M Q2 '26 — Net Income: 4.5M -400M -200M 0 200M 400M 600M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

3.1
OE margin 0.2%
ROIC 3.5%
Accruals -2.6%
Gross margin 52.5%
OCF / EBIT 1.3×
FCF margin 1.6%
OCF margin 5.2%
Profit margin -0.44%
ROA -0.2%
ROCE 2.0%
ROE -0.69%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

3.6
RPO / sales 0.0071×
Segment HHI 0.67 HHI
RPO growth —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

4.5
ND/EBITDA —
Quick ratio 2.1×
Cash / Debt 0.39×
Net debt / Eq 0.42×
Debt / Eq 0.68×
F-score 5.0 pts
Debt payback 16.8 yr
Cash runway —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.8
Sales/sh Y/Y +2.0%
Shares change -0.44%
EBIT CAGR -30.9%
Sales Q/Q +0.76%
Div. growth —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.